ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 13, 2026 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-1. They are seeking to have the statement dec… | Read Filing EDGAR |
| Apr. 13, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated April 13, 2026, informs Gregory D. Gorgas, CEO of Artelo Biosciences, Inc., that the SEC has not reviewed and will not review their registration state… | Read Filing EDGAR |
| Mar. 25, 2026 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-1. They are seeking for the statement to be d… | Read Filing EDGAR |
| Mar. 20, 2026 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-1. They are seeking to have the statement dec… | Read Filing EDGAR |
| Mar. 20, 2026 | CORRESP | Neutral/Informational | Moderate | The correspondence from Craft Capital Management LLC to the SEC indicates their concurrence with Artelo Biosciences, Inc.'s request to accelerate the effective date of their Regis… | Read Filing EDGAR |
| Mar. 13, 2026 | UPLOAD | Neutral/Informational | Moderate | The SEC has communicated to Artelo Biosciences, Inc. that they do not intend to review the company's draft registration statement submitted on March 9, 2026. The SEC has requested… | Read Filing EDGAR |
| Dec. 1, 2025 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC for the acceleration of its Registration Statement on Form S-1, seeking to have it declared effective by December 2, 20… | Read Filing EDGAR |
| Jul. 16, 2025 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC for the acceleration of its Registration Statement on Form S-1, seeking to have it declared effective by July 17, 2025,… | Read Filing EDGAR |
| Jul. 16, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated July 16, 2025, informs Gregory D. Gorgas, CEO of Artelo Biosciences, Inc., that the SEC has not reviewed and will not review their registration statem… | Read Filing EDGAR |